Biote Q3 Revenue Falls Below Analyst Expectations on Soft Procedure Segment
Biote reported that Q3 revenue fell short of analyst expectations, citing softness in its procedure segment.
Biote reported that Q3 revenue fell short of analyst expectations, citing softness in its procedure segment.